Role of adrenoceptors in vasopressin, oxytocin and prolactin responses to conditioned fear stimuli in the rat

Journal of Neuroendocrinology

Volumn 10, Issue 12, 1998, Pages 905-910

  Zou, C J ^a   Onaka, T ^a   Yagi, K ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

Adrenoceptors; Conditioned fear; Oxytocin; Prolactin; Vasopressin

Indexed keywords

3 ISOPROPYLAMINO 1 (7 METHYL 4 INDANYLOXY) 2 BUTANOL; ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; BENOXATHIAN; BETA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; BETA 2 ADRENERGIC RECEPTOR BLOCKING AGENT; METOPROLOL; OXYTOCIN; PROLACTIN; VASOPRESSIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONDITIONING; CONTROLLED STUDY; FEAR; MALE; NEUROENDOCRINE SYSTEM; NONHUMAN; OXYTOCIN RELEASE; PRIORITY JOURNAL; PROLACTIN RELEASE; RAT; VASOPRESSIN RELEASE;

ADRENERGIC ANTAGONISTS; ANIMALS; CONDITIONING (PSYCHOLOGY); ENVIRONMENT; FEAR; INJECTIONS, INTRAVENTRICULAR; MALE; METOPROLOL; OXATHIINS; OXYTOCIN; PROLACTIN; PROPANOLAMINES; RATS; RATS, WISTAR; RECEPTORS, ADRENERGIC; RECEPTORS, ADRENERGIC, ALPHA-1; RECEPTORS, ADRENERGIC, BETA-1; RECEPTORS, ADRENERGIC, BETA-2; STRESS; VASOPRESSINS;

EID: 0031757798     PISSN: 09538194     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2826.1998.00277.x     Document Type: Article

References (36)

1. Onaka T, Yagi K, Hamamura M. Vasopressin secretion: suppression after light and tone stimuli previously paired with footshocks in rats. Exp Brain Res 1988; 71: 291 297.
2. Onaka T, Yagi K. Differential effects of naloxone on neuroendocrine responses to fear-related emotional stress. Exp Brain Res 1990; 81: 53 58.
3. Yagi K. Suppressive vasopressin response to emotional stress, Jpn J Physiol 1992; 42: 681 703.
4. Gray JA. The Psychology of Fear and Stress. Cambridge: Cambridge University Press, 1987.
5. Onaka T, Yagi K. Effects of novelty stress on vasopressin and oxytocin secretion by the pituitary in the rat. J Neuroendocrinol 1993; 5: 365-369.
6. Onaka T, Palmer JR, Yagi K. Norepinephrine depletion impairs neuroendocrine responses to fear but not novel environmental stimuli in the rat. Brain Res 1996; 713: 261 268.
7. Yagi K, Onaka T. Chlordiazepoxide discriminates between the neural circuits mediating neuroendocrine responses to fear- and anxiety-producing stimuli in the rat. Neurosci Res 1996; 24: 151-158.
8. Charney DS, Bremner JD, Redmond DE Jr. Noradrenergic neural substrates for anxiety and fear. In: Bloom FE, Kupfer DJ, eds. Psychopharmacology; the Fourth Generation of Progress, New York: Raven Press, 1995: 387-395.
9. Richardson-Morton KD, Van de Kar LD, Brownfield MS, Lorens SA, Napier TC, Urban JH. Stress-induced renin and corticosterone secretion is mediated by catecholaminergic nerve terminals in the hypothalamic paraventricular nucleus. Neuroendocrinol 1990; 51: 320-327.
10. Davis M, Redmond DE Jr, Baraban JM. Noradrenergic agonists and antagonists: effects on conditioned fear as measured by the potentiated startle paradigm. Psychopharmacol 1979; 65: 111-118.
11. Onaka T, Yagi K. Neurohypophysial responses to emotional stress after deafferentation of sino-aortic baroreceptors in rats. Neurosci Res 1992; 13: 199-206.
12. Onaka T, Yagi K. A histaminergic H2-receptor antagonist, ranitidine, blocks the suppressive vasopressin response to fear-related emotional stress in the rat. Neurosci Res 1992; 15: 199-205.
13. Weitzman RE, Glatz TH, Fisher DA. The effect of hemorrhage and hypertonic saline upon plasma oxytocin and arginine vasopressin in conscious dogs. Endocrinol 1978; 103: 2154-2160.
14. Yagi K. Effects of a histamine H2-receptor antagonist, ranitidine on the vasopressin and oxytocin responses to novelty stress in the rat. Neurosci Res 1994; 19: 357-364.
15. Maren S, DeCola JP, Fanselaw MS. Water deprivation enhances fear conditioning to contextual, but not discrete, conditional stimuli in rats. Behav Neurosci 1994; 108: 645 649.
16. Cassens G, Roffman M, Kuruc A, Orsulak PJ, Schildkraut JJ. Alterations in brain norepinephrine metabolism induced by environmental stimuli previously paired with inescapable shock. Science 1980; 209: 1138-1140.
17. Rasmussen K, Jacobs BL. Single unit activity of locus coeruleus neurons in the freely moving cat. II. Conditioning and pharmacologic studies. Brain Res 1986; 371: 335 344.
18. Tanaka M, Tsuda A, Yokoo H, Yoshida M, Ida Y, Nishimura H. Involvement of the brain noradrenaline system in emotional changes caused by stress in rats. Ann New York Acad Sci 1990; 597: 159 174.
19. Smith MA, Banerjee S, Gold PW, Glowa J. Induction of C-fos mRNA in rat brain by conditioned and unconditioned Stressors. Brain Res 1992; 578: 135 141.
20. Beck CHM, Fibiger HC. Conditioned fear-induced changes in behavior and in the expression of the immediate early gene c-fos: with and without diazepam pretreatment. J Neurosci 1995; 15: 709-720.
21. Onaka T, Yagi K. Role of noradrenergic projections to the bed nucleus of the stria terminalis in neuroendocrine and behavioural responses to fear-related stimuli in rats. Brain Res 1998; 788: 287 293.
22. Charney DS, Heninger GR, Breier A. Noradrenergic function in panic anxiety: effects of yohimbine in healthy subjects and patients with agoraphobia and panic disorder. Arch Gen Psychiatry 1984; 41: 751 763.
23. Redmond DE Jr, Huang YH, Snyder DR, Maas JW. Behavioral effects of stimulation of the nucleus locus coeruleus in the stump-tailed monkey Macaca arctoides. Brain Res 1976; 116: 502-510.
24. Redmond DE Jr. Studies of the nucleus locus coeruleus in monkeys and hypotheses for neuropsychopharmacology. In: Meltzer HY, ed., Psychopharmacology: the Third Generation of Progress, New York: Raven Press, 1987: 967-975.
25. Jeffersonm JW. Social phobia: everyone's disorder? J Clin Psychiatry 1996; 57 (Suppl. 6): 28-32.
26. Cahill L, Prins B, Weber M, McGaugh JL. β-Adrenergic activation and memory for emotional events. Nature 1994; 371: 702 704.
27. Fontana DJ, McCloskey TC, Jolly SK, Commissaris RL. The effects of beta-antagonists and anxiolytics on conflict behavior in the rat. Pharmacol Biochem Behav 1989; 32: 807-813.
28. Cole BJ, Koob GF. Propranolol antagonizes the enhanced conditioned fear produced by corticotropin releasing factor. J Pharmacol Exp Ther 1988; 247: 902-910.
29. Haanwinckel MA, Antunes-Rodrigues J, De Castro e Silva E. Role of central beta-adrenoceptors on stress-induced prolactin release in rats. Horm Metab Res 1991; 23: 318-320.
30. Onaka T, Palmer JR, Yagi K. A selective role of brainstem noradrenergic neurons in oxytocin release from the neurohypophysis following noxious stimuli in the rat. Neuirosci Res 1996; 25: 67-75.
31. Handley SL, Mithani S. Effects of alpha-adrenoceptor agonists and antagonists in a maze-exploration model of 'fear'-motivated behaviour. Naunyn-Schmiedeberg's Arch Pharmacol 1984; 327: 1-5.
32. Cole BJ, Robbins TW. Dissociable effects of lesions to the dorsal or ventral noradrenergic bundle on the acquisition, performance, and extinction of aversive conditioning. Behav Neurosci 1987; 101: 476-488.
33. Kim JJ, Shih JC, Chen K, Chen L, Bao S, Maren S, Anagnostaras SG, Fanselow MS, De Maeyer E, Seif I, Thompson RF. Selective enhancement of emotional, but not motor, learning in monoamine oxidase A-deficient mice. Proc Natl Acad Sci USA 1997; 94: 5929-5933.
34. Yagi K, Onaka T, Yoshida A. Role of NMDA receptors in the emotional memory associated with neuroendocrine responses to conditioned fear stimuli in the rat. Neurosci Res 1998; 30: 279-286.
35. Sakurai H, Kurimoto F, Ohono H, Kanai A, Nomura K, Demura H, Shizume K. A simple and highly sensitive radioimmunoassay for 8-arginc vasopressin in human plasma using a reversed-phase C18 silica column. Folia Endocrinol 1985; 61: 724-736.
36. Higuchi T, Honda K, Fukuoka T, Negoro H, Wakabayashi K. Release of oxytocin during suckling and parturition in the rat. J Endocrinol 1985; 105: 339 346.